| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00257421 |
| P698 | PubMed publication ID | 6883627 |
| P2093 | author name string | S D Harrison | |
| P2860 | cites work | Ataxia and athetosis as side effects of chemotherapy with vincristine in non-Hodgkin's lymphoma | Q28332448 |
| Clinical significance of an increased or decreased serum alkaline phosphatase level | Q39216774 | ||
| Vincristine infusion. A phase I study | Q40734879 | ||
| Pharmacokinetics of vincristine sulfate in adult cancer patients | Q42671013 | ||
| Pharmacokinetics of vincristine sulfate in children | Q42671215 | ||
| Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. | Q43706400 | ||
| Procedures for preclinical toxicologic evaluation of cancer chemotherapeutic agents: protocols of the laboratory of toxicology | Q44825900 | ||
| Clinical experience with vincristine (NSC-67574) in tumors of the central nervous system and other malignant diseases | Q49120230 | ||
| Hematology and clinical chemistry reference values for C57BL/6 X DBA/2 F1 mice | Q52789680 | ||
| Vincristine neurotoxicity in rodents. | Q54108247 | ||
| Vincristine (NSC-67574): a retrospective toxicologic evaluation in monkeys and dogs using weekly intravenous injections for 6 weeks. | Q54762276 | ||
| Some pharmacologic properties of vincristine | Q69988975 | ||
| Antitumor drug toxicity in tumor-free and tumor-bearing mice | Q71262993 | ||
| Toxicologic evaluation of cis-diamminedichloroplatinum II in B6D2F1 mice | Q71846683 | ||
| Initial clinical studies with vincristine | Q76468609 | ||
| CLINICAL EXPERIENCE WITH VINCRISTINE | Q76512663 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 62-65 | |
| P577 | publication date | 1983-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | An investigation of the mouse as a model for vincristine toxicity | |
| P478 | volume | 11 |
| Q48180553 | Antinociceptive Activities of the Methanolic Extract of the Stem Bark of Boswellia dalzielii Hutch. (Burseraceae) in Rats Are NO/cGMP/ATP-Sensitive-K+ Channel Activation Dependent. |
| Q69485717 | The mouse as a model for predicting the myelosuppressive effects of anticancer drugs |
| Q28545041 | The novel tubulin polymerization inhibitor MHPT exhibits selective anti-tumor activity against rhabdomyosarcoma in vitro and in vivo |
Search more.